0000899243-21-021824.txt : 20210603 0000899243-21-021824.hdr.sgml : 20210603 20210603172201 ACCESSION NUMBER: 0000899243-21-021824 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210601 FILED AS OF DATE: 20210603 DATE AS OF CHANGE: 20210603 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Alleva Lawrence M CENTRAL INDEX KEY: 0001553053 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39114 FILM NUMBER: 21993618 MAIL ADDRESS: STREET 1: 1000 WINTER STREET STREET 2: SUITE 3300 CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Galera Therapeutics, Inc. CENTRAL INDEX KEY: 0001563577 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 461454898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 WEST LIBERTY BLVD #100 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 610-725-1500 MAIL ADDRESS: STREET 1: 2 WEST LIBERTY BLVD #100 CITY: MALVERN STATE: PA ZIP: 19355 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-06-01 0 0001563577 Galera Therapeutics, Inc. GRTX 0001553053 Alleva Lawrence M C/O GALERA THERAPEUTICS, INC., 2 W LIBERTY BLVD #100 MALVERN PA 19355 1 0 0 0 Common Stock 2021-06-01 4 P 0 4045 8.5887 A 4045 I By the Lawrence M. Alleva Revocable Trust. Common Stock 6325 D The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.587 to $8.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. /s/ Christopher Degnan, Attorney-in-Fact for Lawrence M. Alleva 2021-06-03